Cognizant Q3 Revenue $5.66B (+4.6%), EPS $1.39; Adds DyFlex Deal and $0.33 Dividend
CTSH sits 61% above its 52-week low of $37.08.
Summary
Cognizant grew Q3 revenue 4.6% to $5.66B with adjusted EPS of $1.49, while GAAP EPS of $1.39 reflected the absence of last year's $390M tax charge. The 10-Q also disclosed a ~$210M DyFlex acquisition and a $0.33 dividend.
Key Events · Earnings and Guidance · CTSH
-
Q3 Revenue Grows 4.6% to $5.66B
Revenue rose $249M from $5,415M a year ago, or 4.8% in constant currency, led by Financial Services (+12.0%) and CMT (+10.5%).
-
GAAP EPS $1.39 on Easy Comparison
Net income of $627M versus $274M a year ago, which absorbed a $390M one-time non-cash OBBBA tax charge; adjusted EPS was $1.49, up 7.2%.
-
Project Leap Costs Weigh on Margin
GAAP operating margin fell to 15.4% from 16.0% on $51M of restructuring charges; total program cost is now estimated at $180M-$250M with ~$200M of 2026 savings.
-
Cash Flow Softens, DSO Stretches
Nine-month operating cash flow was $1,836M versus $2,025M, and DSO rose to 89 days from 81 at December 31, 2025.
Analysis · CTSH · Technology
Cognizant's Q3 revenue of $5.66B grew 4.6% year over year, but GAAP operating margin slipped to 15.4% from 16.0% as $51M of Project Leap restructuring costs hit the quarter. The headline EPS jump to $1.39 from $0.56 is mostly a base effect: last year's quarter carried a $390M one-time non-cash tax charge tied to the OBBBA. Adjusted EPS of $1.49 is the cleaner read, up 7.2%. Cash generation softened, with nine-month operating cash flow of $1,836M versus $2,025M a year ago and DSO stretching to 89 days from 81 at year-end. Management also disclosed two post-quarter items: a definitive agreement to buy Australia's DyFlex Solutions for about $210M cash, and a $0.33 quarterly dividend payable November 25.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTSH was trading at $59.65 on NASDAQ in the Technology sector, with a market capitalization of approximately $29.9B. The 52-week trading range was $37.08 to $87.03. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.